Abstract
The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), an international foundation of public-private partnership, was established in January 2002. The founding principles include: focusing on both prevention and treatment of the 3 diseases; providing additional fund; fostering country ownership, etc. As of September 2010, GFATM had approved 19.4 billion dollars in total for over 780 projects in 153 countries throughout the world.
In 2006, the GFATM Board approved 17.14 million dollar budget to implement the 5 year evaluation, and contracted with a consortium led by a US consulting firm. Under the oversight of the Technical Evaluation Reference Group (TERG), the evaluation focused on 3 overarching questions: (1) organizational efficiency and effectiveness; (2) effectiveness of the partner environment; (3) impact on reduction of the burden of 3 diseases. The 5 year evaluation revealed the effectiveness of the GFATM business model, as well as shortcoming such as lack of good quality data. TERG ensured quality of the evaluation.
